Mario Gabelli Meridian Bioscience Inc Transaction History

Gamco Investors, Inc. Et Al

$8.56 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$31.15 - $33.39 $60,898 - $65,277	-1,955 Reduced 0.88%	219,351 $7.28 Million
Q3 2022 Nov 10, 2022	SELL	$30.9 - $33.55 $991,704 - $1.08 Million	-32,094 Reduced 12.67%	221,306 $6.98 Million
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $51,922 - $70,044	-2,600 Reduced 1.02%	253,400 $6.58 Million
Q4 2021 Feb 11, 2022	BUY	$17.46 - $21.61 $174,600 - $216,100	10,000 Added 4.07%	256,000 $5.22 Million
Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $694,000 - $900,000	40,000 Added 19.42%	246,000 $4.73 Million
Q2 2021 Aug 13, 2021	SELL	$18.01 - $28.32 $36,020 - $56,640	-2,000 Reduced 0.96%	206,000 $4.57 Million
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $59,280 - $89,670	-3,000 Reduced 1.42%	208,000 $5.46 Million
Q3 2020 Nov 06, 2020	SELL	$13.54 - $26.41 $94,780 - $184,870	-7,000 Reduced 3.21%	211,000 $3.58 Million
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $125,440 - $372,640	-16,000 Reduced 6.84%	218,000 $5.08 Million
Q1 2020 May 14, 2020	SELL	$5.57 - $11.5 $55,700 - $115,000	-10,000 Reduced 4.1%	234,000 $1.97 Million
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $189,600 - $243,360	24,000 Added 10.91%	244,000 $2.38 Million
Q3 2019 Nov 01, 2019	BUY	$9.17 - $12.01 $513,520 - $672,560	56,000 Added 34.15%	220,000 $2.09 Million
Q3 2018 Nov 02, 2018	SELL	$14.85 - $16.35 $118,800 - $130,800	-8,000 Reduced 4.65%	164,000 $2.44 Million
Q2 2018 Aug 10, 2018	SELL	$13.8 - $16.8 $41,400 - $50,400	-3,000 Reduced 1.71%	172,000 $2.74 Million
Q3 2017 Nov 01, 2017	BUY	$13.45 - $14.35 $2.35 Million - $2.51 Million	175,000	175,000 $2.5 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account